Look KY - Search Results

1

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.

Barlow TS, Przybylski M, Schilder JM, Moore DH, Look KY. Barlow TS, et al. Among authors: look ky. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):496-500. doi: 10.1111/j.1525-1438.2006.00573.x. Int J Gynecol Cancer. 2006. PMID: 16681717

2

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.

Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, Look KY. Balega J, et al. Among authors: look ky. Int J Gynecol Cancer. 2004 Jan-Feb;14(1):104-9. doi: 10.1111/j.1048-891x.2004.14079.x. Int J Gynecol Cancer. 2004. PMID: 14764037

3

The fate of the ovaries after radical hysterectomy and ovarian transposition.

Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. Feeney DD, et al. Among authors: look ky. Gynecol Oncol. 1995 Jan;56(1):3-7. doi: 10.1006/gyno.1995.1002. Gynecol Oncol. 1995. PMID: 7821844

4

Collagenase expression in ovarian cancer cell lines.

Moore DH, Allison B, Look KY, Sutton GP, Bigsby RM. Moore DH, et al. Among authors: look ky. Gynecol Oncol. 1997 Apr;65(1):78-82. doi: 10.1006/gyno.1997.4628. Gynecol Oncol. 1997. PMID: 9103395

5

A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery.

Schilder JM, Hurteau JA, Look KY, Moore DH, Raff G, Stehman FB, Sutton GP. Schilder JM, et al. Among authors: look ky. Gynecol Oncol. 1997 Dec;67(3):235-40. doi: 10.1006/gyno.1997.4860. Gynecol Oncol. 1997. PMID: 9441769 Clinical Trial.

6

Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.

Hurteau JA, Allison B, Sutton GP, Moore DH, Look KY, Hurd W, Bigsby RM. Hurteau JA, et al. Among authors: look ky. Cancer. 1999 Apr 15;85(8):1810-5. doi: 10.1002/(sici)1097-0142(19990415)85:8<1810::aid-cncr22>3.0.co;2-e. Cancer. 1999. PMID: 10223576

7

Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.

Fakiris AJ, Moore DH, Reddy SR, Look KY, Yiannoutsos CT, Randall ME, Cardenes HR; Hoosier Oncology Group. Fakiris AJ, et al. Among authors: look ky. Gynecol Oncol. 2005 Mar;96(3):818-23. doi: 10.1016/j.ygyno.2004.11.050. Gynecol Oncol. 2005. PMID: 15721431 Clinical Trial.

8

Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma.

Look KY, Moore DH, Sutton GP, Prajda N, Abonyi M, Weber G. Look KY, et al. Anticancer Res. 1997 Jul-Aug;17(4A):2353-6. Anticancer Res. 1997. PMID: 9252646

9

Gynecologic cancers metastatic to the breast.

Moore DH, Wilson DK, Hurteau JA, Look KY, Stehman FB, Sutton GP. Moore DH, et al. Among authors: look ky. J Am Coll Surg. 1998 Aug;187(2):178-81. doi: 10.1016/s1072-7515(98)00119-7. J Am Coll Surg. 1998. PMID: 9704965

10

Vulvar keratoacanthoma.

Gilbey S, Moore DH, Look KY, Sutton GP. Gilbey S, et al. Among authors: look ky. Obstet Gynecol. 1997 May;89(5 Pt 2):848-50. doi: 10.1016/s0029-7844(97)00026-4. Obstet Gynecol. 1997. PMID: 9166347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters